An artificial protein has been engineered that may block malignant properties of cancer cells as well as correct certain birth defects. The findings may lead to identifying new molecular targets suitable for therapeutic intervention.
An artificial protein has been engineered that may block malignant properties of cancer cells as well as correct certain birth defects. The findings may lead to identifying new molecular targets suitable for therapeutic intervention.